| PERIOD ENDING | 5-Apr-09 | 31-Dec-08 | 28-Sep-08 | 29-Jun-08 | | Total Revenue | 482,279 | 609,959 | 714,308 | 692,063 | | Cost of Revenue | 312,207 | 382,856 | 416,891 | 407,167 | | | Gross Profit | 170,072 | 227,103 | 297,417 | 284,896 | | | Operating Expenses | | Research Development | 155,284 | 163,128 | 169,551 | 170,115 | | Selling General and Administrative | 83,757 | 99,608 | 103,744 | 104,470 | | Non Recurring | 25,205 | 558,434 | 1,586 | 20,719 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (94,174) | (594,067) | 22,536 | (10,408) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,863 | 5,231 | 8,028 | 8,220 | | Earnings Before Interest And Taxes | (88,311) | (588,836) | 30,564 | (2,188) | | Interest Expense | 7,236 | 8,013 | 8,993 | 8,959 | | Income Before Tax | (95,547) | (596,849) | 21,571 | (11,147) | | Income Tax Expense | 8,000 | 9,500 | 10,200 | 2,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (103,547) | (606,349) | 11,371 | (13,647) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (103,547) | (606,349) | 11,371 | (13,647) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($103,547) | ($606,349) | $11,371 | ($13,647) |
|
0.45% Nasdaq 
0.20%
Income Statement
